Evidence map›Paper›PMID 41198829›Full record

ArticleJournal of human genetics2026

Long-read genomic analyses to elucidate hidden structural variations associated with MECP2 duplication syndrome.

Qiaowei Liang, Yuri Uchiyama, Rie Seyama, Ichiro Kuki, Kazuhiro Haginoya, Toshiyuki Shinozaki, Mitsuhiro Kato, Masamune Sakamoto, Naomi Tsuchida, Eriko Koshimizu and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Qiaowei LiangDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID http://orcid.org/0000-0002-5207-9588
Yuri UchiyamaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID http://orcid.org/0000-0002-4540-5277
Rie SeyamaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Ichiro KukiDepartment of Pediatric Neurology, Osaka City General Hospital, Osaka, Japan.
Kazuhiro HaginoyaDepartment of Pediatric Neurology, Miyagi Children's Hospital, Sendai, Japan.ORCID http://orcid.org/0000-0003-0150-5716
Toshiyuki ShinozakiDepartment of Pediatrics, Nihonkai General Hospital, Sakata, Japan.
Mitsuhiro KatoDepartment of Pediatrics, Showa Medical University School of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0003-1485-8553
Masamune SakamotoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Naomi TsuchidaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID http://orcid.org/0000-0001-7203-884X
Eriko KoshimizuDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID http://orcid.org/0000-0001-9947-3315
Atsushi FujitaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID http://orcid.org/0000-0003-1572-1014
Satoko MiyatakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID http://orcid.org/0000-0001-7587-5168
Takeshi MizuguchiDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID http://orcid.org/0000-0003-4998-1244
Naomichi MatsumotoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan. naomat@yokohama-cu.ac.jp.ORCID http://orcid.org/0000-0001-9846-6500

Funding

Japan Agency for Medical Research and Development (AMED) JP25ek0109617Japan Agency for Medical Research and Development (AMED) JP25ek0109648Japan Agency for Medical Research and Development (AMED) JP25ek0109674Japan Agency for Medical Research and Development (AMED) JP25ek0109677Japan Agency for Medical Research and Development (AMED) JP25ek0109760MEXT | Japan Society for the Promotion of Science (JSPS) JP21K07869MEXT | Japan Society for the Promotion of Science (JSPS) JP23K07229MEXT | Japan Society for the Promotion of Science (JSPS) JP23K15353MEXT | Japan Society for the Promotion of Science (JSPS) JP23K18278MEXT | Japan Society for the Promotion of Science (JSPS) JP23K27520MEXT | Japan Society for the Promotion of Science (JSPS) JP23K27568MEXT | Japan Society for the Promotion of Science (JSPS) JP24K02230MEXT | Japan Society for the Promotion of Science (JSPS) JP24K18862
6 · The paper itself

Abstract

MECP2 duplication syndrome results from duplication of the MECP2 gene, encoding methyl-CpG-binding protein 2. Structural variations in this region can be detected by short-read next-generation sequencing, but resolving its precise genomic architecture remains challenging because of the involvement of complex and highly repetitive sequences. This study investigated the hidden structural variations using optical genome mapping and targeted long-read nanopore sequencing. We identified 14 breakpoints within the Xq28 regions encompassing MECP2 in four individuals from four families with MECP2 duplication syndrome. Combining the above methods enabled us to identify all the precise breakpoints, except for two inversions embedded within highly repetitive sequences. This also represents the most precise delineation to date of complex structural variants in MECP2 duplication syndrome. Notably, leveraging long nanopore reads (> 75 kb) allowed us to span low-copy repeat regions, including the approximately 72 kb J-group low-copy repeat which was difficult to be resolved, as well as GC-rich segments and dense clusters of short interspersed nuclear elements such as Alu, thus enhancing breakpoint-detection accuracy. We also detected previously underreported rare and complex rearrangement patterns. These findings highlight the power of integrating long-read sequencing with optical genome mapping for the delineation of complex genomic architectures, thus enhancing our understanding of the genomic structure underlying MECP2 duplication syndrome.

Indexed as

Gene DuplicationGenomicsGenomic Structural VariationMethyl-CpG-Binding Protein 2X-Linked Intellectual DisabilityChildChromosome BreakpointsChromosome MappingChromosomes, Human, XFemaleHigh-Throughput Nucleotide SequencingHumansMaleNanopore SequencingPedigreeMECP2 protein, humanMethyl-CpG-Binding Protein 2

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.